» Articles » PMID: 36018524

Prediction of Individual Lymph Node Metastatic Status in Esophageal Squamous Cell Carcinoma Using Routine Computed Tomography Imaging: Comparison of Size-Based Measurements and Radiomics-Based Models

Overview
Journal Ann Surg Oncol
Publisher Springer
Specialty Oncology
Date 2022 Aug 26
PMID 36018524
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Lymph node status is vital for prognosis and treatment decisions for esophageal squamous cell carcinoma (ESCC). This study aimed to construct and evaluate an optimal radiomics-based method for a more accurate evaluation of individual regional lymph node status in ESCC and to compare it with traditional size-based measurements.

Methods: The study consecutively collected 3225 regional lymph nodes from 530 ESCC patients receiving upfront surgery from January 2011 to October 2015. Computed tomography (CT) scans for individual lymph nodes were analyzed. The study evaluated the predictive performance of machine-learning models trained on features extracted from two-dimensional (2D) and three-dimensional (3D) radiomics by different contouring methods. Robust and important radiomics features were selected, and classification models were further established and validated.

Results: The lymph node metastasis rate was 13.2% (427/3225). The average short-axis diameter was 6.4 mm for benign lymph nodes and 7.9 mm for metastatic lymph nodes. The division of lymph node stations into five regions according to anatomic lymph node drainage (cervical, upper mediastinal, middle mediastinal, lower mediastinal, and abdominal regions) improved the predictive performance. The 2D radiomics method showed optimal diagnostic results, with more efficient segmentation of nodal lesions. In the test set, this optimal model achieved an area under the receiver operating characteristic curve of 0.841-0.891, an accuracy of 84.2-94.7%, a sensitivity of 65.7-83.3%, and a specificity of 84.4-96.7%.

Conclusions: The 2D radiomics-based models noninvasively predicted the metastatic status of an individual lymph node in ESCC and outperformed the conventional size-based measurement. The 2D radiomics-based model could be incorporated into the current clinical workflow to enable better decision-making for treatment strategies.

Citing Articles

Threshold size criterion to suspect malignant supraclavicular lymph node < 10 mm in esophageal cancer.

Huang Y, Du J, Li Q, Fan T, Wang Z, Chu F Insights Imaging. 2025; 16(1):50.

PMID: 40045142 PMC: 11883069. DOI: 10.1186/s13244-025-01929-3.


Value of Computed Tomography Scan for Detecting Lymph Node Metastasis in Early Esophageal Squamous Cell Carcinoma.

Zeng Y, Liu Y, Li J, Feng B, Lu J Ann Surg Oncol. 2024; 32(3):1635-1650.

PMID: 39586955 DOI: 10.1245/s10434-024-16568-z.


A F-FDG PET/CT-based deep learning-radiomics-clinical model for prediction of cervical lymph node metastasis in esophageal squamous cell carcinoma.

Yuan P, Huang Z, Yang Y, Bao F, Sun K, Chao F Cancer Imaging. 2024; 24(1):153.

PMID: 39533388 PMC: 11556142. DOI: 10.1186/s40644-024-00799-0.


Artificial intelligence enhances the management of esophageal squamous cell carcinoma in the precision oncology era.

Zhang W, Chang Y, Shi R World J Gastroenterol. 2024; 30(39):4267-4280.

PMID: 39492825 PMC: 11525855. DOI: 10.3748/wjg.v30.i39.4267.


Preoperative identification of small metastatic lymph nodes in esophageal squamous cell carcinoma using CT radiomics of lymph nodes.

Wu Y, Wu L, Ou J, Tang S, Cao J, Fu M Abdom Radiol (NY). 2024; 50(3):1123-1132.

PMID: 39305294 DOI: 10.1007/s00261-024-04585-1.


References
1.
Sugawara K, Yamashita H, Uemura Y, Mitsui T, Yagi K, Nishida M . Numeric pathologic lymph node classification shows prognostic superiority to topographic pN classification in esophageal squamous cell carcinoma. Surgery. 2017; 162(4):846-856. DOI: 10.1016/j.surg.2017.06.013. View

2.
Gabriel E, Attwood K, Du W, Tuttle R, Alnaji R, Nurkin S . Association Between Clinically Staged Node-Negative Esophageal Adenocarcinoma and Overall Survival Benefit From Neoadjuvant Chemoradiation. JAMA Surg. 2015; 151(3):234-45. PMC: 5340565. DOI: 10.1001/jamasurg.2015.4068. View

3.
Rice T, Ishwaran H, Hofstetter W, Schipper P, Kesler K, Law S . Esophageal Cancer: Associations With (pN+) Lymph Node Metastases. Ann Surg. 2016; 265(1):122-129. PMC: 5405457. DOI: 10.1097/SLA.0000000000001594. View

4.
Kutup A, Nentwich M, Bollschweiler E, Bogoevski D, Izbicki J, Holscher A . What should be the gold standard for the surgical component in the treatment of locally advanced esophageal cancer: transthoracic versus transhiatal esophagectomy. Ann Surg. 2014; 260(6):1016-22. DOI: 10.1097/SLA.0000000000000335. View

5.
Rizk N, Ishwaran H, Rice T, Chen L, Schipper P, Kesler K . Optimum lymphadenectomy for esophageal cancer. Ann Surg. 2009; 251(1):46-50. DOI: 10.1097/SLA.0b013e3181b2f6ee. View